Key result
Multiple sclerosis was associated with elevated ACE levels and reduced ACE2 levels in cerebrospinal fluid compared to controls.
Why the study?
Are ACE and ACE2 levels altered in the cerebrospinal fluid of patients with multiple sclerosis compared to controls?
Case-Control (n=37)
Are ACE and ACE2 levels altered in the cerebrospinal fluid of patients with multiple sclerosis compared to controls?
Answers are grounded in this paper and cite their sources.
The study demonstrates an alteration of the intrathecal renin-angiotensin system in patients with multiple sclerosis, characterized by elevated ACE and reduced ACE2 levels in the CSF.
BACKGROUND: We reported a reduction in the levels of angiotensin II in cerebrospinal fluid (CSF) from patients with multiple sclerosis (MS). OBJECTIVE AND METHODS: To clarify the mechanism underlying this reduction, we assayed angiotensin-converting enzyme (ACE) and ACE2 concentrations along with angiotensin II concentrations in CSF samples from 20 patients with MS and 17 controls with non-neurological diseases. RESULTS: ACE levels were significantly elevated in patients with MS compared with controls (48.42 +/- 4.84 vs 44.71 +/- 3.9 pg/mL), whereas ACE2 levels were significantly reduced (2.56 +/- 0.26 vs 2.78 +/- 0.24 pg/mL), acting toward a normalization of angiotensin II levels. CONCLUSION: These results further indicate an alteration of the intrathecal renin-angiotensin system in patients with MS.
No takes yet. Share an insight, caveat, or question.
Kawajiri et al. (2008) conducted a case-control in Multiple sclerosis (n=37). Multiple sclerosis vs. Controls with non-neurological diseases was evaluated on ACE levels in cerebrospinal fluid (pg/mL). Multiple sclerosis was associated with elevated ACE levels and reduced ACE2 levels in cerebrospinal fluid compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: